This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_MARGINAL_ZONE_LYMPHOMA_EXALLC for full statistics.
Marginal zone B-cell lymphoma
C3_MARGINAL_ZONE_LYMPHOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
286 |
4. Check minimum number of eventsNone |
286 |
5. Include endpointsNone |
286 |
6. Filter based on genotype QC (FinnGen only) |
286 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Marginal zone B-cell lymphoma
based on the number of shared cases.
Similar with more cases:
- Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 286 | 142 | 144 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.06 |
| Median age at first event (years) | 65.42 | 64.05 | 66.77 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 265
- Matched controls
- 2651
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
5891.1
281.5
220
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
35.4
80.0
105
48
XW000
NOMESCO Finland
Bone marrow biopsy
29.7
75.9
105
57
JN4BD
NOMESCO Finland
Extensive body CT
11.3
55.8
120
180
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
36.1
52.8
68
25
9699/3-C16.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of stomach, NOS
+∞
37.4
35
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
24.9
36.1
51
25
JN6AD
NOMESCO Finland
CT of torso and neck
45.0
34.6
42
11
WF002
NOMESCO Finland
Radical radiotherapy
11.1
34.4
69
81
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
+∞
34.1
32
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
59.1
31.2
36
7
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
312.4
28.3
28
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
34.4
28.0
36
12
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
31.7
27.5
36
13
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.3
26.8
52
56
A03FA01
ATC
metoclopramide; systemic, rectal
4.8
26.5
110
342
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
34.0
25.7
33
11
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
74.7
24.3
27
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
40.4
23.5
29
8
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.9
23.3
137
570
EP1AE
NOMESCO Finland
Neck ultrasound examination
8.4
23.1
53
76
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
49.8
22.8
27
6
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
65.6
21.2
24
*
JN4AD
NOMESCO Finland
Body CT examination
5.8
20.3
62
132
9699/3-C42.1
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of bone marrow
+∞
20.0
19
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.3
19.4
41
51
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
6.8
19.0
50
87
9699/3-C77.8
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
19.0
18
*
1XC02
NOMESCO Finland
NA
47.7
18.5
22
5
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
56.7
18.2
21
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
16.1
18.1
29
20
M04AA01
ATC
allopurinol; systemic
4.3
17.8
74
218
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.4
17.5
39
53
L03AA02
ATC
filgrastim; parenteral
11.6
17.2
32
31
9699/3-C34.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lung, NOS
+∞
16.8
16
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.8
16.6
60
153
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
35.8
16.0
20
6
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
15.8
15
*
C83.8
ICD-10 Finland
Other non-follicular lymphoma
169.4
15.6
16
*
9699/3-C07.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of parotid gland
+∞
14.7
14
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
16.6
14.7
23
15
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
14.2
114
543
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
32.0
14.1
18
6
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.8
13.7
40
79
CAA30
NOMESCO Finland
Biopsy of orbit
+∞
13.7
13
*
L03AA13
ATC
pegfilgrastim; parenteral
7.0
13.2
33
53
PJA10
NOMESCO Finland
Exploration of lymph nodes
14.0
13.2
22
17
ZX120
NOMESCO Finland
Intravenous
4.1
13.0
54
156
A04AA02
ATC
granisetron; systemic, transdermal
5.5
12.9
39
81
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
73.4
12.7
14
*
A04AA01
ATC
ondansetron; systemic, rectal
5.2
12.7
40
87
WW500
NOMESCO Finland
Blood transfusion
7.2
12.4
30
46
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
39.5
12.3
15
*
CFA20
NOMESCO Finland
Biopsy of conjunctiva
39.5
12.3
15
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
49.0
12.0
14
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
15.6
12.0
19
13
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
14.5
11.6
19
14
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
11.5
11
*
R50.9
ICD-10 Finland
Fever, unspecified
3.6
11.5
56
184
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.6
10.9
52
168
H02AB06
ATC
prednisolone; systemic
2.4
10.9
149
918
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
13.7
10.8
18
14
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
10.6
58
207
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
34.0
10.4
13
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
10.7
10.2
19
19
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.4
10.1
51
172
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
57.1
9.7
11
*
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
31.2
9.5
12
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
9.4
142
891
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
+∞
9.4
9
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
10.1
9.4
18
19
CBA10
NOMESCO Finland
Biopsy of eyelid
25.0
9.0
12
5
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
13.1
9.0
15
12
A02BC02
ATC
pantoprazole; systemic
2.3
9.0
195
1439
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
51.7
8.7
10
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
8.7
119
707
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.6
8.5
29
69
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
9.9
8.4
16
17
9699/3-C08.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of submandibular gland
+∞
8.4
8
*
C88.4
ICD-10 Finland
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]
+∞
8.4
8
*
9699/3-C44.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of skin, NOS
+∞
8.4
8
*
9699/3-C80.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of unknown primary site
+∞
8.4
8
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
8.4
90
476
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
7.6
8.1
18
25
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
46.3
7.8
9
*
ZX112
NOMESCO Finland
Subcutaneous
7.1
7.7
18
27
WZC30
NOMESCO Finland
Teaching
2.9
7.5
49
195
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
82.2
7.5
8
*
1AA09
NOMESCO Finland
NA
82.2
7.5
8
*
Z3231
NOMESCO Finland
Registered nurse
2.2
7.4
91
508
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
7.3
7
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
16.3
7.3
11
7
WF004
NOMESCO Finland
Palliative radiotherapy
6.9
7.2
17
26
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.0
7.2
22
47
H02AB02
ATC
dexamethasone; systemic
3.0
7.0
43
163
ZX090
NOMESCO Finland
Other technic of radiotherapy
5.1
7.0
21
44
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.7
6.8
28
81
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
23.2
6.7
9
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.7
6.5
14
19
C82.1
ICD-10 Finland
Follicular lymphoma grade II
14.8
6.4
10
7
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
4.5
6.3
21
50
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.8
6.3
40
158
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
27.4
6.3
8
*
ZX108
NOMESCO Finland
Inhalation
27.4
6.3
8
*
L01AA02
ATC
chlorambucil; oral
27.4
6.3
8
*
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
27.4
6.3
8
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.0
6.3
35
126
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
6.3
6.1
15
25
H02AB07
ATC
prednisone; oral
2.4
6.1
52
240
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021879) Hepatitis B virus core Ab [Presence] in Serum
143
137
19.88
142.62
1.2
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
168
252
14.73
122.21
1.4
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
159
225
14.66
120.51
1.3
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
154
218
14.14
116.20
1.3
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
71
21
44.64
115.05
1.5
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
73
29
33.46
107.87
1.5
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
67
33
26.21
90.85
1.6
1.2
—
—
—
0
0
(4035726)
137
230
10.51
87.61
2.1
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
114
195
9.06
70.13
3.7
2.7
g/l
9.8
10.3
0.42
109
175
(3028026) IgM [Mass/volume] in Serum or Plasma
100
159
9.13
65.11
2.5
1.9
g/l
2.2
1.5
0.74
95
143
(3011412) CD3 cells [#/volume] in Blood
48
24
23.83
63.97
3.8
2.2
e9/l
1.0
1.0
0.10
31
12
(3042111) Morphology [Interpretation] in Bone marrow Narrative
58
46
15.56
61.63
1.4
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
98
178
7.85
56.01
1.8
2.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
37
16
26.41
51.90
2.5
2.6
%
17.8
14.5
—
13
8
(42870588) Differential panel, method unspecified - Blood
202
805
6.14
47.66
10.2
5.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
245
1186
8.43
45.34
11.0
5.2
e9/l
0.6
0.6
0.12
229
1018
(3006315) Basophils [#/volume] in Blood
244
1192
8.13
44.20
11.0
5.2
e9/l
0.0
0.0
0.40
230
1030
(3019198) Lymphocytes [#/volume] in Blood
245
1208
8.17
43.71
11.1
5.3
e9/l
1.8
2.0
0.48
235
1060
(3022096) Basophils/100 leukocytes in Blood
232
1093
6.95
43.49
11.7
5.3
%
0.7
0.7
1.30
227
1019
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
33
17
21.81
42.97
4.9
2.3
e6/l
587.7
919.9
—
18
7
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
33
17
21.81
42.97
2.5
2.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
234
1120
6.99
42.77
11.8
5.4
%
2.9
2.8
0.22
229
1042
(3013115) Eosinophils [#/volume] in Blood
244
1229
7.71
41.52
11.5
5.4
e9/l
0.2
0.2
0.25
230
1072
(3018010) Neutrophils/100 leukocytes in Blood
232
1124
6.64
41.12
11.2
5.3
%
56.9
57.4
0.27
225
1051
(3013650) Neutrophils [#/volume] in Blood by Automated count
250
1390
7.34
34.94
20.6
9.1
e9/l
3.5
4.1
7.63
244
1218
(3024561) Albumin [Mass/volume] in Serum or Plasma
217
1083
5.16
34.49
7.4
4.5
g/l
35.6
35.1
0.59
209
1009
(3020630) Protein [Mass/volume] in Serum or Plasma
84
210
5.25
32.96
2.2
2.7
g/l
67.4
67.1
0.12
78
187
(3027945) Reticulocytes/100 erythrocytes in Blood
102
305
4.64
32.03
3.9
2.5
%
1.9
1.8
0.34
97
271
(3023520) Reticulocytes [#/volume] in Blood
86
231
4.89
30.78
3.9
2.6
e9/l
74.5
69.3
0.44
74
179
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
26
18
15.79
29.15
5.4
3.8
%
28.3
36.3
—
12
6
(3017181) Myelocytes/100 leukocytes in Blood
80
215
4.78
28.43
6.0
4.0
%
0.8
0.8
0.05
41
79
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
105
6.11
27.68
2.0
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
105
6.11
27.68
2.0
1.9
g/l
6.8
7.5
1.54
44
81
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
105
5.97
26.60
2.0
1.9
g/l
4.0
3.8
0.08
42
76
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
25
0
+∞
26.46
1.1
0.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
98
6.12
26.41
2.0
1.9
g/l
3.0
3.1
0.13
43
78
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
221
1258
4.33
25.95
9.2
6.4
mmol/l
1.2
1.2
0.81
188
1054
(3021440) Promyelocytes/100 leukocytes in Blood
74
201
4.62
25.76
6.3
4.1
%
0.1
0.2
0.08
36
71
(3002179) Metamyelocytes/100 leukocytes in Blood
71
189
4.67
25.32
6.1
3.9
%
0.5
0.4
0.21
27
53
(3037756) Immunofixation for Serum or Plasma
37
53
7.87
25.23
1.3
1.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
48
91
6.14
25.16
1.9
2.3
g/l
2.1
0.8
0.91
42
79
(40760888) Immunoglobulin light chains.free panel - Serum
39
63
7.01
23.85
1.5
4.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
113
436
3.63
23.82
2.0
1.4
g/l
2.0
2.8
3.39
90
258
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
31
41
8.36
22.53
1.3
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
35
54
7.25
22.29
4.7
6.2
iu/ml
416.0
153.6
—
6
8
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
30
41
8.06
21.19
1.3
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
28
36
8.51
20.78
1.3
1.4
u/ml
95.7
98.1
—
6
7
(21494814) CD8 cells/100 lymphocytes in Specimen
24
6
43.50
19.83
2.3
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
64
189
4.07
19.59
6.4
4.2
%
0.0
0.2
0.66
29
61
(3015377) Calcium [Moles/volume] in Serum or Plasma
159
840
3.01
18.71
5.1
3.2
mmol/l
2.4
2.4
0.17
149
728
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
26
36
7.84
18.11
2.2
2.0
pg
33.9
33.0
0.42
26
36
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
35
67
5.81
17.99
2.0
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
150
784
2.92
17.74
5.5
3.8
ph
7.4
7.4
0.22
38
148
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
109
483
3.03
17.39
4.1
2.9
mmol/l
2.5
2.5
0.35
109
425
(40768804) Tissue Pathology biopsy report
170
967
2.87
16.86
2.7
2.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
22
8
29.62
16.76
1.5
1.0
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
28
47
6.50
16.38
4.9
3.1
%
1.2
1.0
0.11
22
40
(3021589) Normoblasts [#/volume] in Blood
177
1055
2.78
15.60
15.7
9.9
e9/l
0.0
0.0
0.43
165
859
(40760892) CBC W Ordered Manual Differential panel - Blood
107
497
2.84
15.34
9.2
4.8
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
19
7
28.92
14.47
2.3
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
121
623
2.63
13.92
14.5
6.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
30
63
5.20
13.89
1.5
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
132
716
2.57
13.54
5.9
4.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
18
7
27.29
13.54
5.6
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
20
31
6.86
12.54
5.7
2.2
%
46.2
54.5
0.60
12
23
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
22
38
6.19
12.46
1.0
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
21
35
6.40
12.31
1.0
1.1
u/ml
331.9
324.7
0.03
14
22
(3048929) Epstein Barr virus Ab [Presence] in Serum
24
47
5.48
11.96
1.2
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
34
91
4.11
11.68
1.8
2.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
112
611
2.37
10.82
5.9
3.9
%
85.8
88.7
0.67
102
598
(3032080) INR in Blood by Coagulation assay
165
1068
2.29
10.56
5.4
9.0
inr
1.1
1.2
4.13
45
306
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
105
564
2.36
10.45
3.3
2.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
14
18
8.13
10.23
1.1
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
10
11.40
10.22
2.9
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
10
11.40
10.22
2.9
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
10
11.40
10.22
2.9
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
10
11.40
10.22
2.9
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
127
754
2.23
9.84
3.9
2.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
19
7.70
9.78
2.1
2.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
19
36
5.58
9.77
6.4
3.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
34
104
3.58
9.65
3.5
2.0
g/l
1.6
1.5
0.22
29
90
(40768797) Stomach Pathology biopsy report
75
359
2.48
9.53
2.0
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
21
45
4.96
9.46
2.2
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
165
1105
2.17
9.25
6.2
4.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
19
38
5.28
9.23
1.6
3.2
—
—
—
0
0
(3002256) Pathology report gross observation
67
311
2.51
9.06
1.5
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
28
5.99
8.90
3.0
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
10
10.33
8.69
3.0
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
62
4.13
8.61
2.1
1.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
24
62
4.13
8.61
2.4
1.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
33
5.41
8.51
1.1
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
27
5.81
8.11
2.6
1.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
103
605
2.10
7.83
2.6
2.1
mg/l
3.2
3.2
0.03
95
524
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
70
353
2.30
7.78
2.5
2.3
%
25.5
23.1
0.42
61
304
(3016650) Hepatitis A virus Ab [Presence] in Serum
18
40
4.74
7.76
1.1
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
75
398
2.20
7.34
2.7
2.2
umol/l
13.9
13.1
0.27
70
364
(3004789) Transferrin [Mass/volume] in Serum or Plasma
71
369
2.23
7.31
2.5
2.2
g/l
2.2
2.3
0.48
66
336
(3019309) Folate [Moles/volume] in Red Blood Cells
85
478
2.11
7.15
1.7
1.7
nmol/l
1257.7
1213.7
0.16
66
356
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
76
415
2.13
6.87
2.7
2.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
17
6.69
6.82
1.9
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
22
65
3.58
6.56
1.4
1.3
u/ml
2.7
2.3
—
8
12
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
22
66
3.53
6.42
1.4
1.3
u/ml
2.1
8.1
—
10
16
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
78
3.27
6.20
2.0
2.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
137
946
1.86
6.17
3.6
2.6
ug/l
290.0
140.4
1.91
128
860
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
19
5.98
6.15
1.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
50
243
2.28
5.97
6.6
3.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
71
398
2.04
5.91
2.6
1.8
s
29.7
29.6
0.08
66
386
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
10
9
11.46
5.84
3.0
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
10
9
11.46
5.84
3.0
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
24
5.18
5.79
1.0
3.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
24
5.18
5.79
2.7
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
24
5.18
5.79
2.8
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
24
5.18
5.79
2.7
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
28
4.82
5.79
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
48
237
2.23
5.51
2.1
2.2
g/l
0.2
0.2
0.26
42
221
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
136
963
1.79
5.44
2.9
2.1
nmol/l
80.7
78.8
0.29
130
829
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
21
70
3.16
5.22
1.1
1.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
39
181
2.34
5.17
2.7
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
43
209
2.24
5.12
6.8
9.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
19
5.42
5.07
2.4
3.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
23
4.93
5.05
2.6
2.6
—
—
—
0
0
(4062490)
11
23
4.93
5.05
1.5
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
77
3.01
5.05
2.3
2.6
u/ml
0.3
0.5
1.08
14
41
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
55
297
2.05
5.02
2.3
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
56
3.36
4.98
1.1
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
139
1009
1.73
4.96
2.3
2.0
pmol/l
92.1
94.7
0.26
81
513
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
53
288
2.03
4.75
2.0
4.0
ug/l
2.5
48.2
1.04
38
244
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
48
3.47
4.68
1.1
1.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
40
3.63
4.39
5.6
2.2
e9/l
3.0
4.7
2.66
14
40
(3035637) Corticotropin [Mass/volume] in Plasma
10
22
4.67
4.33
1.7
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
199
1631
1.72
4.27
5.2
4.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
68
417
1.83
4.24
2.8
3.1
e6/l
2.6
2.2
0.16
41
234
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
53
301
1.93
4.18
2.3
2.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
77
496
1.76
4.06
3.6
3.8
ng/l
121.8
228.0
0.50
61
405
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
70
2.84
4.01
1.2
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
43
3.37
3.96
7.0
2.9
%
56.2
55.8
0.02
14
43
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
19
71
2.80
3.91
1.9
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
260
2337
2.24
3.88
32.4
15.3
mg/l
19.8
24.6
1.23
242
1862
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
21
84
2.62
3.81
2.4
2.4
ug/l
127.6
294.4
1.20
21
77
(3000492) Spirometry study
38
199
2.05
3.75
1.9
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
42
229
1.98
3.71
4.6
3.5
mmol/l
2.1
1.9
0.11
35
187
(3026782) Osmolality of Urine
76
501
1.70
3.65
2.9
3.0
mosm/kgh2o
513.1
563.8
1.52
69
421
(3018095) Leukocytes [#/volume] in Urine
120
891
1.60
3.61
4.2
3.9
e6/l
75.0
95.7
0.23
84
630
(3003694) ABO and Rh group [Type] in Blood
86
588
1.66
3.60
1.5
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
9
7.94
3.58
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
9
7.94
3.58
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
9
7.94
3.58
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
9
7.94
3.58
1.0
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
107
775
1.61
3.55
3.7
3.3
e6/l
21.6
148.2
0.87
82
594
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
36
3.44
3.52
1.0
2.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
31
3.65
3.52
1.1
2.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
41
227
1.94
3.47
5.7
7.5
mmol/l
1.2
1.4
0.40
41
216
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
135
2.19
3.41
1.4
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
37
3.34
3.38
1.2
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
95
679
1.60
3.29
3.8
3.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
19
78
2.54
3.29
1.7
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
60
381
1.73
3.28
2.1
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
67
440
1.68
3.24
2.9
2.9
e6/l
0.8
1.1
0.54
39
252
(3030467) Casts [#/volume] in Urine by Automated count
98
708
1.58
3.24
3.8
3.2
e6/l
0.3
0.6
1.31
72
526
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
28
3.66
3.22
1.4
2.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
92
2.38
3.18
3.4
1.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
40
229
1.87
3.07
4.8
3.5
kpa
5.9
5.8
0.20
40
223
(3037522) Nuclear Ab [Titer] in Serum
48
291
1.78
3.07
1.3
1.3
titre
1224.4
560.6
0.98
18
70
(3008536) Aspergillus sp Ab [Presence] in Serum
6
8
7.63
3.07
3.8
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
40
3.09
3.01
1.0
2.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
5
10.14
2.99
1.2
1.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
5
10.14
2.99
3.4
2.8
iu/ml
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
119
913
1.52
2.95
4.2
3.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
13
5.49
2.88
1.0
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
27
138
2.06
2.86
5.5
9.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
30
160
1.98
2.84
1.8
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
18
4.54
2.81
1.3
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
99
737
1.53
2.80
3.7
3.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
31
3.31
2.80
1.2
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
29
154
1.98
2.78
1.3
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
6
8.45
2.76
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
6
8.45
2.76
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
6
8.45
2.76
1.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
6
8.45
2.76
1.4
2.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
60
2.58
2.75
1.3
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
10
6.10
2.71
1.2
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
17
74
2.38
2.63
1.5
1.2
—
5.3
—
0
5
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
15
4.75
2.61
1.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
38
2.97
2.61
1.1
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
42
257
1.74
2.61
2.0
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
25
3.68
2.59
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
20
4.08
2.58
1.1
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
7
7.24
2.56
1.0
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
20
95
2.19
2.55
2.9
3.0
g/l
1.5
0.3
—
9
36
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
246
2240
1.70
2.53
28.5
14.7
ml/min/173m2
76.9
76.8
0.03
233
1831
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
102
783
1.47
2.43
3.1
2.4
u/l
58.8
54.8
0.45
93
715
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
22
111
2.06
2.43
5.2
3.9
mmol/l
24.3
24.2
0.04
22
100
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
12
5.08
2.41
1.0
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
198
1725
1.48
2.41
4.1
4.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
8
6.34
2.38
1.2
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
35
2.92
2.33
1.1
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
73
528
1.51
2.32
1.7
1.7
mg/l
1.4
1.3
0.09
56
418
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
41
2.75
2.30
1.4
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
41
2.75
2.30
2.1
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
13
4.69
2.28
2.2
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
13
4.69
2.28
2.2
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
73
532
1.50
2.23
3.1
2.6
e6/l
5.0
4.7
0.10
63
469
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
9
5.63
2.22
1.2
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
9
5.63
2.22
1.2
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
24
3.40
2.19
1.3
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
83
623
1.47
2.19
1.7
1.6
nmol/l
20.1
21.3
0.26
74
508
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
9
30
3.06
2.16
1.2
2.9
nmol/l
2.1
4.1
—
9
30
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
14
4.35
2.16
2.2
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
14
4.35
2.16
2.2
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
25
3.26
2.11
1.3
1.0
—
—
—
0
0
(4211845)
5
10
5.07
2.08
2.2
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
20
3.56
2.07
1.6
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
32
2.87
2.02
1.0
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
13
57
2.34
2.01
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
7
21
3.39
1.97
1.3
2.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
45
2.50
1.95
1.7
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
45
2.50
1.95
1.7
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
27
3.02
1.95
1.5
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
16
3.81
1.94
2.2
1.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
16
3.81
1.94
1.2
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
16
3.81
1.94
2.2
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
28
167
1.75
1.92
1.9
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
22
122
1.87
1.90
6.7
2.9
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
7
22
3.23
1.89
1.3
2.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
34
2.70
1.88
4.2
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
21
116
1.87
1.84
2.4
2.9
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
8
29
2.81
1.80
1.5
1.6
mosm/kgh2o
275.0
277.2
—
8
19
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
36
2.55
1.75
4.2
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
36
2.55
1.75
4.2
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
36
2.55
1.75
4.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
36
2.55
1.75
4.2
1.4
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
6
19
3.20
1.67
1.3
1.3
u/l
166.5
272.0
—
6
19
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
19
3.20
1.67
1.2
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
19
3.20
1.67
1.2
2.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
39
265
1.55
1.65
3.8
3.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
21
121
1.79
1.63
1.5
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
14
3.61
1.62
1.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
14
3.61
1.62
1.2
3.3
nmol/l
58.2
99.7
—
5
14
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
22
129
1.76
1.62
2.3
2.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
23
138
1.72
1.57
7.4
10.7
mmol/l
24.8
24.5
0.30
23
129
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
86
1.91
1.53
2.8
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
121
1020
1.32
1.52
3.2
3.9
ng/l
22.7
40.3
2.26
90
769
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
37
2.48
1.49
4.2
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
9
37
2.48
1.49
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
223
2055
1.39
1.49
31.5
16.6
%
37.4
39.4
1.70
146
1396
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
206
2223
0.74
1.47
6.1
6.2
mmol/mol
39.7
40.4
0.51
187
2045
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
168
1489
1.31
1.44
3.7
3.2
u/l
51.0
51.8
0.05
157
1369
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
193
1744
1.33
1.44
3.9
3.7
pmol/l
14.8
14.9
0.28
180
1532
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
60
458
1.39
1.42
1.3
1.2
u/ml
7.2
1.0
0.63
11
119
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
24
151
1.64
1.40
6.8
3.1
mmol/l
1.2
2.0
0.59
18
121
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
23
2.64
1.37
2.7
3.2
u/ml
25.7
84.2
—
6
23
(3012441) Differential panel - Pleural fluid
6
23
2.64
1.37
2.0
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
24
152
1.63
1.37
2.9
2.3
e9/l
5.0
3.9
0.89
17
104
(44790049)
8
34
2.39
1.30
1.4
1.8
—
—
—
0
0
(44806118)
8
34
2.39
1.30
1.4
1.8
—
—
—
0
0
(44790047)
8
34
2.39
1.30
1.4
1.8
—
—
—
0
0
(44790048)
8
34
2.39
1.30
1.4
1.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
91
754
1.30
1.26
2.2
2.0
u/l
203.2
197.4
0.02
83
699
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
50
380
1.38
1.22
1.3
1.3
iu/ml
34.1
33.9
0.00
18
122
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
19
2.66
1.22
1.2
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
132
1152
1.27
1.21
3.4
3.8
estimate
0.0
0.0
0.00
30
209
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
141
1241
1.27
1.20
2.5
2.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
64
1.91
1.20
1.8
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
38
2.14
1.19
1.1
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
61
759
0.75
1.18
3.0
3.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
13
72
1.84
1.17
3.3
2.3
mg/l
1.6
1.6
0.07
13
63
(3013512) EKG study
93
785
1.27
1.10
4.4
4.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
59
1.90
1.09
1.3
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
67
545
1.30
1.05
3.2
3.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
17
107
1.63
1.02
1.6
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
27
191
1.46
0.99
3.4
4.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
95
814
1.25
0.98
2.5
3.3
ng/l
1685.1
1329.9
0.30
83
697
(3000494) Fungus identified in Specimen by Culture
39
297
1.36
0.96
2.1
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
51
1.79
0.95
1.1
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
39
298
1.36
0.94
1.2
1.3
—
—
—
0
0
(4306422)
6
27
2.25
0.94
1.7
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
10
55
1.85
0.93
3.0
1.4
e6/l
46188.0
24381.7
—
10
36
(40768793) Breast Pathology biopsy report
11
63
1.78
0.91
1.2
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
131
1171
1.22
0.90
3.5
3.8
estimate
0.0
0.0
0.00
31
196
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
29
2.09
0.90
1.0
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
46
365
1.31
0.87
1.2
1.3
u/ml
6.4
10.4
0.34
17
127
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
64
1.75
0.87
1.0
1.4
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
31
1.96
0.85
1.3
1.6
ug/l
28.5
16.9
—
6
31
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
65
1.72
0.83
1.5
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
62
515
1.26
0.83
1.5
1.8
pmol/l
566.9
446.5
0.77
51
421
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
66
1.69
0.80
1.5
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
66
1.69
0.80
1.5
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
33
1.84
0.79
1.2
1.5
—
—
—
0
0
(4146454)
0
27
0.00
0.78
0.0
2.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
38
1.86
0.74
1.4
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
21
151
1.42
0.73
1.3
1.3
—
36.8
—
0
10
(3024928) Oxygen saturation in Venous blood
9
56
1.63
0.73
2.3
2.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
25
2.02
0.73
1.0
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
16
109
1.50
0.72
1.2
1.1
iu/ml
183.3
148.2
—
7
39
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
59
1.54
0.69
4.4
1.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
42
1.68
0.69
3.1
2.7
mmol/l
4.2
4.0
—
7
42
(3035285) Chloride [Moles/volume] in Venous blood
7
42
1.68
0.69
3.1
2.7
mmol/l
107.3
106.0
—
7
42
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
42
1.68
0.69
3.1
2.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
78
1.56
0.66
2.0
3.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
127
1158
1.17
0.65
5.0
5.2
estimate
0.0
0.0
0.00
30
210
(3022145) Colonoscopy Study observation
35
280
1.28
0.65
1.4
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
29
1.74
0.64
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
56
654
0.82
0.63
1.8
1.6
mmol/l
1.4
1.4
0.00
47
540
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
63
1.61
0.62
1.9
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
38
309
1.26
0.62
7.7
7.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
222
2308
0.83
0.62
4.4
4.6
mmol/l
1.4
1.5
1.84
198
2083
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
30
1.68
0.61
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
30
1.68
0.61
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
30
1.68
0.61
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
30
1.68
0.61
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
30
1.68
0.61
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
30
1.68
0.61
1.0
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.3
—
0.1
—
0
12
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
53
1.52
0.59
1.0
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
24
186
1.32
0.56
5.3
4.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
241
2331
1.22
0.55
5.2
4.9
mmol/l
6.0
6.0
0.51
217
2102
(3045424) Erythrocytes [Presence] in Urine
6
38
1.59
0.54
1.0
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
231
2382
0.84
0.50
5.0
5.3
mmol/l
2.5
2.7
1.34
206
2149
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
222
2138
1.17
0.50
5.0
4.5
mu/l
1.9
2.6
0.58
203
1904
(3048689) Calprotectin [Mass/mass] in Stool
29
237
1.25
0.47
2.2
2.1
ug/g
157.4
144.5
0.10
24
187
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
28
340
0.80
0.47
4.6
4.7
%
28.9
31.7
0.87
17
216
(1616796) Gas panel - Central venous blood
7
49
1.44
0.46
2.7
2.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
128
0.69
0.44
1.7
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
19
239
0.78
0.43
1.4
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
31
1.62
0.43
1.4
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
226
2327
0.86
0.43
4.4
4.7
mmol/l
4.4
4.6
1.14
202
2116
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
16
0.00
0.41
0.0
1.3
—
1.7
—
0
9
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
102
0.68
0.40
1.1
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
42
366
1.17
0.38
21.6
23.7
inr
1.1
1.3
—
7
41
(3021788) Differential panel - Synovial fluid
5
36
1.40
0.38
1.2
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
36
1.40
0.38
1.2
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
248
2425
1.17
0.36
25.2
14.2
—
—
—
0
0
(4034850)
6
86
0.69
0.33
9.8
11.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
2.5
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
47
1.28
0.32
3.7
2.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
47
1.28
0.32
1.3
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
52
1.35
0.31
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
10
75
1.35
0.30
1.2
1.4
—
—
—
0
0
(4094501)
8
63
1.28
0.28
1.3
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
97
1.25
0.23
1.4
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
94
0.74
0.22
1.3
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
98
1.23
0.21
1.7
1.3
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
39.0
—
0
6
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
106.7
—
0
6
(44806420)
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.1
—
136.5
—
0
12
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
43
1.17
0.21
1.0
1.8
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
4.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
18
208
0.86
0.21
4.9
3.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
7.3
—
0
6
(3037556) Urate [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
151
0.85
0.16
1.7
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
65
616
1.07
0.16
3.6
4.1
estimate
0.0
0.0
0.00
31
197
(1002224) Polysomnography panel
7
89
0.78
0.14
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
12
104
1.16
0.12
4.3
4.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
133
1.13
0.12
1.1
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
47
496
0.94
0.12
3.9
4.1
kg/l
1.0
1.0
—
10
69
(3041096) Erythrocytes [Presence] in Urine by Automated
65
624
1.05
0.11
3.3
3.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
88
1.02
0.07
1.4
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
90
880
1.03
0.07
3.7
4.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
142
0.91
0.06
3.2
4.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
105
0.85
0.06
1.0
2.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
56
543
1.04
0.06
2.9
3.0
ug/l
0.7
0.7
0.04
36
365
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
222
2237
0.97
0.06
4.0
4.2
mmol/l
1.4
1.3
1.48
196
2006
(3009508) Creatinine [Moles/volume] in Urine
78
766
1.03
0.04
3.2
3.0
mmol/l
7.3
7.4
0.10
60
624
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
93
943
0.98
0.03
4.8
5.1
ug/l
2.5
2.4
0.06
84
832
(4010399)
20
191
1.05
0.03
1.5
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
20
192
1.04
0.02
2.2
3.0
ml/min/173m2
52.4
61.1
—
8
82
(3012516) Albumin [Mass/volume] in Urine
74
749
0.98
0.02
3.2
3.2
mg/l
1843.6
228.1
0.70
46
476
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
74
746
0.99
0.00
4.4
4.5
%
20.5
20.8
0.06
35
363
(3020682) Albumin/Creatinine [Ratio] in Urine
80
794
1.01
0.00
3.8
3.9
mg/mmol
9.2
9.0
0.01
45
490
(3022621) pH of Urine by Test strip
17
169
1.01
0.00
1.9
2.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
26
263
0.99
0.00
1.4
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
17.9
—
1721.9
—
0
8
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
81
0.99
0.00
4.4
5.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
9.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
12.1
—
1052.5
—
0
8
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
9.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(4198724)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.3
—
0.6
—
0
6
(40768800) Prostate Pathology biopsy report
6
61
0.98
0.00
1.5
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
9.5
—
0
9
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
2.0
—
1.2
—
0
7
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
49
1.02
0.00
1.0
3.7
u/ml
13.2
31.4
—
5
49
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.0
—
1.2
—
0
6
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
194.6
—
0
9
(3006576) Bicarbonate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
6.8
—
24.9
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MARGINAL_ZONE_LYMPHOMA – Marginal zone B-cell lymphoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).